Literature DB >> 3382264

P component in the synovium in rheumatoid and osteoarthritis.

M G Butler1, A J D'Ardenne, D L Scott.   

Abstract

P component is present in amyloid deposits, normal serum, and normal tissues in relation to elastic fibres. Its pathological role in inflammatory synovitis was investigated. Its distribution was determined immunohistologically in 33 synovia: 15 rheumatoid; seven osteoarthritic; seven traumatic controls; and four infected biopsy specimens. P component was present in two circumscribed distributions: extracellular fibrils in dense fibroelastic tissue of the more fibrotic synovia; and in the arterial wall, where it was confined to a single elastic lamina in some cases and in others showed reduplication and fragmentation. These were not related to amyloid material. It shows no disease specificity, but P component categorises the nature of the pathological reaction and is typically in biopsy specimens showing the development of chronic fibrosis. There was close codistribution of P component with elastic tissue, though this was not absolute. P component had a different distribution from C reactive protein (in synovial lining cell layer), and fibronectin, which was absent from fibrotic areas. Understanding the pathological interactions of P component may help elucidate why some synovial reactions remain inflammatory and other progress to chronic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382264      PMCID: PMC1003546          DOI: 10.1136/ard.47.6.463

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin.

Authors:  D J Unsworth; D L Scott; T J Almond; H K Beard; E J Holborow; K W Walton
Journal:  Br J Exp Pathol       Date:  1982-04

2.  Immunohistochemical studies of amyloid P component in disorders of cutaneous elastic tissue.

Authors:  S M Breathnach; S M Melrose; B Bhogal; F C de Beer; M M Black; M B Pepys
Journal:  Br J Dermatol       Date:  1982-10       Impact factor: 9.302

3.  Amyloid P component is located on elastic fibre microfibrils in normal human tissue.

Authors:  S M Breathnach; S M Melrose; B Bhogal; F C de Beer; R F Dyck; G Tennent; M M Black; M B Pepys
Journal:  Nature       Date:  1981-10-22       Impact factor: 49.962

4.  Reticulin and its related structural connective tissue proteins in the rheumatoid synovium.

Authors:  D L Scott; M Salmon; K W Walton
Journal:  Histopathology       Date:  1984-05       Impact factor: 5.087

5.  Significance of fibronectin in rheumatoid arthritis and osteoarthrosis.

Authors:  D L Scott; A C Wainwright; K W Walton; N Williamson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

6.  Fibrin and fibronectin in rheumatoid synovial membrane and rheumatoid synovial fluid.

Authors:  I Clemmensen; B Hølund; R B Andersen
Journal:  Arthritis Rheum       Date:  1983-04

7.  Microdeposition of amyloid in the joints.

Authors:  Y A Goffin; Y Thoua; P R Potvliege
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

8.  The distribution of fibronectin in the pannus in rheumatoid arthritis.

Authors:  D L Scott; J P Delamere; K W Walton
Journal:  Br J Exp Pathol       Date:  1981-08

9.  Fibronectin production by synovial intimal cells.

Authors:  P I Mapp; P A Revell
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

10.  Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component.

Authors:  F C de Beer; M L Baltz; S Holford; A Feinstein; M B Pepys
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  1 in total

1.  Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation.

Authors:  Diane D Shao; Rahul Suresh; Varsha Vakil; Richard H Gomer; Darrell Pilling
Journal:  J Leukoc Biol       Date:  2008-03-10       Impact factor: 4.962

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.